Veterinary Medicines

WELLICOX 50 MG/ML SOLUTION INJECTABLE POUR BOVINS, PORCINS ET CHEVAUX

Not authorised
  • Flunixin
Download as PDF

Product identification

Medicine name:
WELLICOX 50 MG/ML SOLUTION INJECTABLE POUR BOVINS, PORCINS ET CHEVAUX
Уеликокс 50 mg/ml инжекционен разтвор за говеда, свине и коне
Active substance:
  • Flunixin
Target species:
  • Cattle
  • Pig
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Flunixin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
    • Pig
  • Intravenous use
    • Cattle
    • Horse
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Bulgaria
Package description:
  • Boîte de 1 flacon verre de 100 mL
  • Boîte de 1 flacon verre de 250 mL
  • Boîte de 1 flacon plastique de 50 mL
  • Boîte de 1 flacon plastique de 100 mL
  • Boîte de 1 flacon plastique de 250 mL
  • Boîte de 1 flacon verre de 50 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Animal Health Bulgaria EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
  • Vetem SPA
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1947
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0241/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 28/09/2023
Updated on: 30/09/2023
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 28/09/2023
Updated on: 30/09/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."